utpatents-US8906891

Download pdf
Abstract/Description: This process relates to a pharmaceutical composition of an Na-K-ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition may be used to treat a skin disorder. In another embodiment, the composition may be used to inhibit cardiac fibrosis.
Subject(s): 514/175
514/25
514/61
Date Issued: 2014-12-09